İçeriğe geç

Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS

@spjuraschek.bsky.social did:plc:hduofm275xjwl65blurpayye

Internist, hypertension specialist, epidemiologist, and trialist interest in healthy food access, sodium, heart disease, blood pressure regulation, and gout

Bluesky’a katılma tarihi:

Takipçi
954
Takip edilen
443
Post
481
Sıralamaya girdiği gün
0

Özet

Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS (@spjuraschek.bsky.social), 14 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 954 takipçisi var, 443 hesabı takip ediyor ve 481 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • American Journal of Hypertension@amjhypertension.bsky.social

    #HotOffThePress Effects of Anti-Hypertensive Agents on Orthostatic Changes: Secondary Analysis of the Treatment of Mild Hypertension Study (TOMHS) academic.oup.com/ajh/advance-...

    Postu göster
  • Marwah Abdalla, MD MPH@marwahabdalla.bsky.social

    We have more ways to measure blood pressure than ever before but not necessarily more confidence in what those measurements mean. Our NHLBI workshop report in @jaccjournals.bsky.social chaired w/ @spjuraschek.bsky.social provides an implementation roadmap. www.sciencedirect.com/science/arti...

    Postu göster
  • Andrew Michael South, MD, MS@asouth-neph.bsky.social

    Terrific to learn from and work with you @spjuraschek.bsky.social and so many of the fantastic #Hypertension folks out there #BloodPressure #LifeSpan www.sciencedirect.com/science/arti...

    Postu göster
  • Alex Chang, MD@alexchangmd.bsky.social

    Interesting paper - Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. Naturally, nephrology, transplant, internal med are discussing the most (it's part of the job). ID, endocrine, sports medicine and GI > than cardiology? pubmed.ncbi.nlm.nih.gov/39661402/

    Postu göster
  • Iain Bressendorff, MD PhD@ibressendorff.bsky.social

    Huge fan of spiro, but wouldn’t use it first-line if I didn’t suspect hyperaldosteronism. No CVD outcome data and the side effects for men are not trivial. Don’t feel that the modest effect on BP in primary HTN justifies its use over A/C/D.

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.

Bu hesap kimseyi bloklamıyor.